| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/04/2003 | US6528497 Anticoagulant and antithrombotic like heparin; hexadeca saccharides of three distinct sequences: a sulphated penta saccharide sequence DEFGH, a non-sulphated heptasaccharide sequence Z(MN)3 and a sulphated tetrasaccharide sequence VWXY. |
| 03/04/2003 | US6528487 Including GMP-140, ELAM-1, and lymphocyte-homing receptor. |
| 03/03/2003 | WO2002020496A1 2-guanidino-4-aryl-quinazoline |
| 03/03/2003 | CA2421222A1 2-guanidino-4-aryl-quinazoline |
| 02/27/2003 | WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof |
| 02/27/2003 | WO2003016549A2 Nucleic-acid associated proteins |
| 02/27/2003 | WO2003016348A2 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 02/27/2003 | WO2003016341A2 Regulation of iron uptake |
| 02/27/2003 | WO2003016335A2 Irreversible cysteine protease inhibitors of legumain |
| 02/27/2003 | WO2003016334A1 Methods for purification of an activated peg solution and for the synthesis of a modified hemoglobin solution |
| 02/27/2003 | WO2003016302A1 Diamine derivatives |
| 02/27/2003 | WO2003016299A1 Quinazolinone derivative |
| 02/27/2003 | WO2003016279A1 Fused-polycyclic compounds |
| 02/27/2003 | WO2003016273A2 Peptide arginals and methods for treating disseminated intravascular coagulation |
| 02/27/2003 | WO2003016269A1 5-amidino-n-(2-aminophenethyl)-n-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, and intermediate therefor |
| 02/27/2003 | WO2003015831A1 Gas microsphere liposome composites |
| 02/27/2003 | WO2003015801A1 Hemostatic material, complex hemostatic material and method of hemostasis |
| 02/27/2003 | WO2003015799A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/27/2003 | WO2003015794A1 Methods and compositions for treating apoptosis associated disorders |
| 02/27/2003 | WO2003015772A1 Inhibitors of polyq-aggregation |
| 02/27/2003 | WO2003015757A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 02/27/2003 | WO2003015753A1 Liposome preparations |
| 02/27/2003 | WO2003015748A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/27/2003 | WO2003015715A2 Tetrahydroquinoline derivatives as antithrombotic agents |
| 02/27/2003 | WO2003015700A2 Novel vasoconstrictor cannabinoid analogs |
| 02/27/2003 | WO2003015606A2 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 02/27/2003 | WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/27/2003 | WO2002100862A3 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 02/27/2003 | WO2002097046A3 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | WO2002096471A3 Viral inactivation process using antioxidant |
| 02/27/2003 | WO2002094180A3 Pharmaceutically active isoindoline derivatives |
| 02/27/2003 | WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/27/2003 | WO2002090325A3 Benzazepinone alpha v integrin receptor antagonists |
| 02/27/2003 | WO2002080853A3 Fused heterocyclic inhibitors of factor xa |
| 02/27/2003 | WO2002072542A3 Ph-dependent nmda receptor antagonists |
| 02/27/2003 | WO2002067869A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/27/2003 | WO2002064590A3 Carboline derivatives |
| 02/27/2003 | WO2002060951A3 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii |
| 02/27/2003 | WO2002046193A3 Heterocyclic ether substituted imidazoquinolines |
| 02/27/2003 | WO2002038157A3 Inhibitors of thromboxane formation and action |
| 02/27/2003 | WO2002028865A3 Condensed pyridoindole derivatives |
| 02/27/2003 | WO2002022212A3 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 02/27/2003 | WO2002020767A3 G-csf analog compositions and methods |
| 02/27/2003 | WO2002017711A3 Therapeutics and diagnostics based on a novel signal transduction system in platelets |
| 02/27/2003 | WO2002000691A3 Polynucleotides and polypeptides encoded thereby |
| 02/27/2003 | US20030040541 Administering bismuth subgallate to inhibit the production of nitric oxide synthases (NOS) |
| 02/27/2003 | US20030040536 For therapy of disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 02/27/2003 | US20030040523 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 02/27/2003 | US20030040517 For use in therapy of pain, fever, inflammation of a variety of conditions and diseases |
| 02/27/2003 | US20030040509 Methods and compositions for treating diseases associated with excesses in ACE |
| 02/27/2003 | US20030040508 Altering the conformational equilibrium of the A- ring of a 1 alpha -hydroxylated vitamin D compound to favor a chair conformation for A-ring that presents the 1 alpha-hydroxyl in an axial orientation |
| 02/27/2003 | US20030040499 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-beta (TGF-beta) |
| 02/27/2003 | US20030040487 Polymer complexes of glucuronoglucanes |
| 02/27/2003 | US20030040095 Generation of preferential protein for use in the trement of thrombosis and heart defscts; obtain cells, transform with vector containing preferential protein, recover transformed cells, propagate, recover protein |
| 02/27/2003 | US20030040052 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of human cancers |
| 02/27/2003 | US20030039999 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | US20030039683 Multilayer binding; lamellar surface structure |
| 02/27/2003 | US20030039669 Use of a composition containing an effective quantity of at least one chelating agent for partially or totally reducing the symptoms associated with histamine release in the organism |
| 02/27/2003 | US20030039654 Amino acid sequence of parathyroid hormone/parathyroid hormone related protein modulating domains and a vehicle for to stimulate renal calcium reabsorption |
| 02/27/2003 | US20030039640 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus |
| 02/27/2003 | US20030039629 Espression enhancer for protein synthesis inhibitory genes |
| 02/27/2003 | US20030039626 Fat-binding polymers |
| 02/27/2003 | US20030039611 Selectively binds to antigen to cause cell impairment |
| 02/27/2003 | US20030037701 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 02/27/2003 | CA2459692A1 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/27/2003 | CA2458643A1 Nucleic-acid associated proteins |
| 02/27/2003 | CA2458068A1 Methods and compositions for treating apoptosis associated disorders |
| 02/27/2003 | CA2457632A1 Identification and isolation of somatic stem cells and uses thereof |
| 02/27/2003 | CA2457482A1 5-amidino-n-(2-aminophenethyl)-2-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, and intermediate therefor |
| 02/27/2003 | CA2457452A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/27/2003 | CA2457436A1 Peptide arginals and methods for treating disseminated intravascular coagulation |
| 02/27/2003 | CA2456988A1 Gas microsphere liposome composites |
| 02/27/2003 | CA2456868A1 Inhibitors of polyq-aggregation |
| 02/27/2003 | CA2456843A1 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 02/27/2003 | CA2456841A1 Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors |
| 02/27/2003 | CA2455974A1 Methods for purification of an activated peg solution and for the synthesis of a modified hemoglobin solution |
| 02/26/2003 | EP1285916A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing TNF alpha levels |
| 02/26/2003 | EP1285087A2 Enzymatic assays for screening anti-cancer agents |
| 02/26/2003 | EP1284994A2 Use a high-molecular-weight extracellular haemoglobin as blood substitute |
| 02/26/2003 | EP1284973A2 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 02/26/2003 | EP1284961A1 Glycinamides |
| 02/26/2003 | EP1284958A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives |
| 02/26/2003 | EP1284956A1 Il-8 receptor antagonists |
| 02/26/2003 | EP1284743A2 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 02/26/2003 | EP1284739A1 Composition and method for intervening neuronal death using sulfasalazine |
| 02/26/2003 | EP1284734A1 Protein kinase inhibitors |
| 02/26/2003 | EP1284724A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 02/26/2003 | EP1284717A1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 02/26/2003 | EP0969827B1 Mixture of primary fatty acids obtained from sugar cane wax |
| 02/26/2003 | EP0934304B1 2-pyrimidineamine derivatives and processes for their preparation |
| 02/26/2003 | EP0798295B1 Novel amidinonaphthyl derivative or salt thereof |
| 02/26/2003 | EP0759943B1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 02/26/2003 | EP0710114B1 A coagulation factor viii formulation |
| 02/26/2003 | CN1399678A Human Enzymes of metalloprotease family |
| 02/26/2003 | CN1399646A Recombinant fusion molecules |
| 02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
| 02/26/2003 | CN1399638A Indoloazepines as vasopressin receptor antagonists |
| 02/26/2003 | CN1399636A Adenosine receptor antagonists and methods of making and using the same |
| 02/26/2003 | CN1399560A Novel albumin-free factor VIII formulations |
| 02/26/2003 | CN1398969A Prepn of modification enzyme for earthworm fibrinolysin |